Today's article highlights the performance of the munKNEE Psychedelic Drug Stocks Index which tracks the six (6) largest psychedelic stocks researching the treatment of mental illnesses based on the use of ten (10) different psychedelic compounds.

We highlight the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances.

In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.

In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.

Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.